Investor List:

Top Diagnostics Seed Investors in New York City (39)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Manufacturing (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Manufacturing (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Manufacturing (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Iain Dukes, Venture Partner at OrbiMed
Iain Dukes
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Peter Thompson, Partner at OrbiMed
Peter Thompson
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY), Investors in San Francisco (CA)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Cybersecurity (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Peter Steelman, Partner at Deerfield Management
Peter Steelman
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Photo of Abby Hunter-Syed, Partner at LDV Capital
Abby Hunter-Syed
LDV Capital·Partner
Sweet spot: $775K
Range: $500K - $1.5M
Investors in New York City
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Impact (Pre-seed), Investors in Fashion (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in Fashion (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Impact (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in AI (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Analytics (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Seed), Investors in Fashion (Seed), Investors in Impact (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in Entertainment & Sports (Seed), Investors in Gaming/eSports (Seed), Investors in Fashion (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Entertainment & Sports (Seed), Investors in Impact (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in Gaming/eSports (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Seed), Investors in Female Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Jennifer Hartt, Managing Director at Ben Franklin Technology Partners of Southeastern Pennsylvania
Jennifer Hartt
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Philadelphia (PA)
Photo of Will Weisman, Managing Partner at KittyHawk Ventures
Will Weisman
KittyHawk Ventures·Managing Partner
Sweet spot: $2.0M
Range: $250K - $15.0M
Investors in New York (NY), Investors in Warsaw (Poland), Investors in Vancouver (BC), Investors in San Francisco (CA), Investors in Hayward (CA), Investors in Dallas (TX), Investors in San Diego (CA), Investors in Detroit (MI), Investors in Boston (MA)
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in DeepTech (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in IoT (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in IoT (Pre-seed), Investors in Robotics (Pre-seed), Investors in BioTech (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in IoT (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Robotics (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in IoT (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Space (Pre-seed), Investors in IoT (Pre-seed), Investors in AI (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in AI (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in IoT (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Robotics (Pre-seed), Investors in AI (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Robotics (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in IoT (Pre-seed), Investors in AI (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in Robotics (Seed), Investors in Space (Seed), Investors in IoT (Seed), Investors in TransportationTech (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in TransportationTech (Seed), Investors in TransportationTech (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Space (Seed), Investors in Web3/Blockchain (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Robotics (Seed), Investors in IoT (Seed), Investors in IoT (Seed), Investors in Web3/Blockchain (Seed), Investors in IoT (Seed), Investors in TransportationTech (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in TransportationTech (Seed), Investors in Robotics (Seed), Investors in IoT (Seed), Investors in Web3/Blockchain (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in TransportationTech (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in IoT (Seed), Investors in AI (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Robotics (Seed), Investors in IoT (Seed), Investors in TransportationTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in AI (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in IoT (Series A), Investors in Robotics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Space (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in TransportationTech (Series A), Investors in Robotics (Series A), Investors in DeepTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in TransportationTech (Series A), Investors in Space (Series A), Investors in Web3/Blockchain (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in IoT (Series A), Investors in TransportationTech (Series A), Investors in DeepTech (Series A), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Robotics (Series A), Investors in Web3/Blockchain (Series A), Investors in IoT (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Medical Devices (Series A), Investors in TransportationTech (Series A), Investors in AI (Series A), Investors in TransportationTech (Series A), Investors in Space (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in IoT (Series A), Investors in Web3/Blockchain (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in TransportationTech (Series A), Investors in BioTech (Series A), Investors in Robotics (Series A), Investors in IoT (Series A), Investors in Medical Devices (Series A), Investors in AI (Series A), Investors in Web3/Blockchain (Series A), Investors in Robotics (Series A), Investors in DeepTech (Series A), Investors in BioTech (Series A), Investors in TransportationTech (Series A), Investors in IoT (Series A), Investors in AI (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Austin (Other Lists), Investors in Midwest (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)